\-\ Texto\\:\\ \ \(0\)\
\-\ normal\ \(4026\)\
\-\ the\\ patient\\ is\\ in\\ good\\ general\\ condition\\ and\\ he\\ is\\ seizure\\-free\\ after\\ surgery\\.\ \(0\)\
\-\ conventional\\ multiplanar\\ mr\\ imaging\\ demonstrates\\ a\\ cortically\\-based\\ mass\\ lesion\\ in\\ the\\ anteromedial\\ portion\\ of\\ the\\ left\\ temporal\\ lobe\\.\\ the\\ lesion\\ is\\ hyperintense\\ on\\ t2\\-weighted\\ \\ and\\ flair\\ sequences\\,\\ possibly\\ containing\\ a\\ small\\ cystic\\ space\\ in\\ the\\ medial\\ portion\\.\\ on\\ t1\\-weighted\\ sequence\\ the\\ lesion\\ is\\ slightly\\ hypointense\\ compared\\ to\\ gray\\ matter\\ signal\\ intensity\\.\\ there\\ is\\ no\\ edema\\ or\\ mass\\ effect\\ in\\ the\\ surrounding\\ brain\\ parenchyma\\.\\ following\\ contrast\\ administration\\,\\ the\\ mass\\ enhances\\ strongly\\ and\\ homogeneously\\,\\ except\\ from\\ the\\ small\\ cystic\\ region\\ in\\ the\\ medial\\ aspect\\ of\\ the\\ mass\\.\\ \ \(0\)\
\-\ the\\ imaging\\ findings\\ are\\ more\\ compatible\\ with\\ a\\ \\ low\\-grade\\ intra\\-axial\\ neoplasm\ \(0\)\
\-\ anaplastic\\ ganglioglioma\\ \\(who\\ grade\\ iii\\)\ \(0\)\
\-\ ganglioglioma\ \(14\)\
\-\ low\\-grade\\ diffuse\\ \\ astrocytoma\ \(1\)\
\-\ oligodendroglioma\ \(21\)\
\-\ dnet\ \(1\)\
\-\ an\\ otherwise\\ healthy\\ 14\\-year\\ old\\ boy\\ presents\\ with\\ 1\\-month\\ history\\ of\\ complex\\ partial\\ seizures\\.\ \(0\)\
\-\ in\\ the\\ clinical\\ setting\\ of\\ complex\\ partial\\ seizures\\,\\ ganglioglioma\\ is\\ one\\ of\\ the\\ most\\ common\\ tumors\\ we\\ have\\ to\\ think\\,\\ despite\\ the\\ fact\\ that\\ the\\ typical\\ imaging\\ appearance\\ of\\ a\\ circumscribed\\ cyst\\ with\\ mural\\ nodule\\ is\\ not\\ present\\.\\ in\\ this\\ case\\ \\,\\ a\\ major\\ differential\\ diagnosis\\ would\\ be\\ diffuse\\ low\\ grade\\ astrocytoma\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ganglioglioma\\:\\ 0\\.07435461266081138\ \(0\)\
\-\ low\\-grade\\:\\ 0\\.051546792960693484\ \(0\)\
\-\ seizure\\-free\\:\\ 0\\.040011681002002725\ \(0\)\
\-\ cortically\\-based\\:\\ 0\\.03801431593743049\ \(0\)\
\-\ 14\\-year\\:\\ 0\\.03801431593743049\ \(0\)\
\-\ 1\\-month\\:\\ 0\\.03801431593743049\ \(0\)\
\-\ seizures\\:\\ 0\\.0361956144577718\ \(0\)\
\-\ complex\\:\\ 0\\.03371321061688805\ \(0\)\
\-\ partial\\:\\ 0\\.03366852928520932\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.03269310540564824\ \(0\)\
\-\ grade\\:\\ 0\\.03206735756601941\ \(0\)\
\-\ think\\:\\ 0\\.031185279675756145\ \(0\)\
\-\ portion\\:\\ 0\\.030494646772010706\ \(0\)\
\-\ intra\\-axial\\:\\ 0\\.03008605035893738\ \(0\)\
\-\ imaging\\:\\ 0\\.02958729789835866\ \(0\)\
\-\ anteromedial\\:\\ 0\\.027980414817917975\ \(0\)\
\-\ multiplanar\\:\\ 0\\.02719054954661167\ \(0\)\
\-\ medial\\:\\ 0\\.02692905924719263\ \(0\)\
\-\ anaplastic\\:\\ 0\\.0265100060072973\ \(0\)\
\-\ dnet\\:\\ 0\\.026353608478654048\ \(0\)\
\-\ lesion\\:\\ 0\\.02572249102463726\ \(0\)\
\-\ diffuse\\:\\ 0\\.02548775783621\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.024674167163527973\ \(0\)\
\-\ homogeneously\\:\\ 0\\.024565896687080806\ \(0\)\
\-\ cystic\\:\\ 0\\.02428209563794836\ \(0\)\
\-\ mural\\:\\ 0\\.02396194436150281\ \(0\)\
\-\ conventional\\:\\ 0\\.023868110888740773\ \(0\)\
\-\ sequence\\:\\ 0\\.023868110888740773\ \(0\)\
\-\ strongly\\:\\ 0\\.023424016814877237\ \(0\)\
\-\ mass\\:\\ 0\\.02341795087581408\ \(0\)\
\-\ compatible\\:\\ 0\\.023257014097263044\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.02309548787646013\ \(0\)\
\-\ we\\:\\ 0\\.02215778478044428\ \(0\)\
\-\ fact\\:\\ 0\\.02215778478044428\ \(0\)\
\-\ possibly\\:\\ 0\\.021541217573774293\ \(0\)\
\-\ containing\\:\\ 0\\.02137035275609996\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.021314689922336743\ \(0\)\
\-\ except\\:\\ 0\\.021314689922336743\ \(0\)\
\-\ setting\\:\\ 0\\.021259649032690803\ \(0\)\
\-\ gray\\:\\ 0\\.020595021850920506\ \(0\)\
\-\ hypointense\\:\\ 0\\.019967214232358334\ \(0\)\
\-\ enhances\\:\\ 0\\.019883718871206744\ \(0\)\
\-\ iii\\:\\ 0\\.019761070833661288\ \(0\)\
\-\ major\\:\\ 0\\.019680969745622962\ \(0\)\
\-\ despite\\:\\ 0\\.01956320855915225\ \(0\)\
\-\ small\\:\\ 0\\.019394830387991318\ \(0\)\
\-\ is\\:\\ 0\\.019389337185680193\ \(0\)\
\-\ flair\\:\\ 0\\.019298909477909295\ \(0\)\
\-\ healthy\\:\\ 0\\.018978688638948724\ \(0\)\
\-\ circumscribed\\:\\ 0\\.018710534912076717\ \(0\)\
\-\ good\\:\\ 0\\.018012133619467827\ \(0\)\
\-\ parenchyma\\:\\ 0\\.017927924588141228\ \(0\)\
\-\ compared\\:\\ 0\\.01781783937290972\ \(0\)\
\-\ general\\:\\ 0\\.017736860425406467\ \(0\)\
\-\ condition\\:\\ 0\\.017604785265551013\ \(0\)\
\-\ sequences\\:\\ 0\\.017578789910374443\ \(0\)\
\-\ hyperintense\\:\\ 0\\.017476158940409704\ \(0\)\
\-\ administration\\:\\ 0\\.017476158940409704\ \(0\)\
\-\ nodule\\:\\ 0\\.01735080590759609\ \(0\)\
\-\ slightly\\:\\ 0\\.017015892897818092\ \(0\)\
\-\ typical\\:\\ 0\\.016879047754433486\ \(0\)\
\-\ temporal\\:\\ 0\\.016856605308444024\ \(0\)\
\-\ matter\\:\\ 0\\.0165737929576394\ \(0\)\
\-\ tumors\\:\\ 0\\.015811410628918724\ \(0\)\
\-\ intensity\\:\\ 0\\.0152151264846271\ \(0\)\
\-\ otherwise\\:\\ 0\\.015119779475006626\ \(0\)\
\-\ would\\:\\ 0\\.014980132406020146\ \(0\)\
\-\ effect\\:\\ 0\\.014904227847631749\ \(0\)\
\-\ in\\:\\ 0\\.014530938970353619\ \(0\)\
\-\ neoplasm\\:\\ 0\\.014335746679369104\ \(0\)\
\-\ boy\\:\\ 0\\.014308974285349612\ \(0\)\
\-\ space\\:\\ 0\\.013923926143234653\ \(0\)\
\-\ surrounding\\:\\ 0\\.013838252533816578\ \(0\)\
\-\ mr\\:\\ 0\\.013375366856878986\ \(0\)\
\-\ differential\\:\\ 0\\.013364334134743496\ \(0\)\
\-\ aspect\\:\\ 0\\.013223112977750529\ \(0\)\
\-\ clinical\\:\\ 0\\.012952265024955686\ \(0\)\
\-\ brain\\:\\ 0\\.0126667562724274\ \(0\)\
\-\ appearance\\:\\ 0\\.01203894865386523\ \(0\)\
\-\ following\\:\\ 0\\.011947181068478563\ \(0\)\
\-\ edema\\:\\ 0\\.011906027041533452\ \(0\)\
\-\ region\\:\\ 0\\.01188966121792765\ \(0\)\
\-\ he\\:\\ 0\\.011744765231689751\ \(0\)\
\-\ low\\:\\ 0\\.011705261344169457\ \(0\)\
\-\ one\\:\\ 0\\.011407543760150957\ \(0\)\
\-\ lobe\\:\\ 0\\.01132672585184007\ \(0\)\
\-\ cyst\\:\\ 0\\.011312173083872426\ \(0\)\
\-\ signal\\:\\ 0\\.01109888832646689\ \(0\)\
\-\ common\\:\\ 0\\.011016094640179296\ \(0\)\
\-\ who\\:\\ 0\\.010975213838136464\ \(0\)\
\-\ the\\:\\ 0\\.010896495346098585\ \(0\)\
\-\ more\\:\\ 0\\.010527962114838257\ \(0\)\
\-\ surgery\\:\\ 0\\.010221670267784606\ \(0\)\
\-\ a\\:\\ 0\\.009768468025088703\ \(0\)\
\-\ most\\:\\ 0\\.009718399712946187\ \(0\)\
\-\ diagnosis\\:\\ 0\\.009666105077736058\ \(0\)\
\-\ present\\:\\ 0\\.009507432285377738\ \(0\)\
\-\ contrast\\:\\ 0\\.009422540329102983\ \(0\)\
\-\ case\\:\\ 0\\.009209381442695916\ \(0\)\
\-\ demonstrates\\:\\ 0\\.009195178333266926\ \(0\)\
\-\ have\\:\\ 0\\.009115458514113753\ \(0\)\
\-\ findings\\:\\ 0\\.008959787861034284\ \(0\)\
\-\ after\\:\\ 0\\.008709365530094593\ \(0\)\
\-\ presents\\:\\ 0\\.008599232982797664\ \(0\)\
\-\ \\,\\:\\ 0\\.008001282724648888\ \(0\)\
\-\ that\\:\\ 0\\.0072708410273833665\ \(0\)\
\-\ on\\:\\ 0\\.0071319311563096364\ \(0\)\
\-\ normal\\:\\ 0\\.006599076131030055\ \(0\)\
\-\ be\\:\\ 0\\.006491412430265661\ \(0\)\
\-\ there\\:\\ 0\\.0062646086525368905\ \(0\)\
\-\ from\\:\\ 0\\.006238599572188238\ \(0\)\
\-\ not\\:\\ 0\\.006082850599713968\ \(0\)\
\-\ an\\:\\ 0\\.00582100918366862\ \(0\)\
\-\ history\\:\\ 0\\.005813864717768884\ \(0\)\
\-\ are\\:\\ 0\\.005738294938569467\ \(0\)\
\-\ or\\:\\ 0\\.004933609600806441\ \(0\)\
\-\ this\\:\\ 0\\.004734666075439079\ \(0\)\
\-\ left\\:\\ 0\\.0047098781737582\ \(0\)\
\-\ old\\:\\ 0\\.004310022644641648\ \(0\)\
\-\ no\\:\\ 0\\.004238641136471931\ \(0\)\
\-\ patient\\:\\ 0\\.0042196646843171825\ \(0\)\
\-\ to\\:\\ 0\\.00420756757086686\ \(0\)\
\-\ \\(\\:\\ 0\\.0035584321489845346\ \(0\)\
\-\ \\)\\:\\ 0\\.003514964000558153\ \(0\)\
\-\ of\\:\\ 0\\.003443462092551382\ \(0\)\
\-\ and\\:\\ 0\\.0026602316118061837\ \(0\)\
\-\ with\\:\\ 0\\.001729125755023001\ \(0\)\
\-\ \\.\\:\\ 0\\.001573871058503037\ \(0\)\
